Assenagon Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.05M | Sell |
|
|||||
|
2025
Q2 | $88.2M | Buy |
|
|||||
|
2025
Q1 | $85.8M | Buy |
|
|||||
|
2024
Q4 | $5.78M | Sell |
|
|||||
|
2024
Q3 | $9.66M | Buy |
|
|||||
|
2024
Q2 | $4.01M | Sell |
|
|||||
|
2024
Q1 | $10.4M | Buy |
|
|||||
|
2023
Q4 | $6.03M | Sell |
|
|||||
|
2023
Q3 | $6.09M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $7.07M | Sell |
|
|||||
|
2022
Q4 | $7.7M | Sell |
|
|||||
|
2022
Q3 | $11.9M | Buy |
|
|||||
|
2022
Q2 | $8.98M | Buy |
|
|||||
|
2022
Q1 | $2.23M | Sell |
|
|||||
|
2021
Q4 | $7.68M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $16.4M | Sell |
|
|||||
|
2021
Q1 | $25.7M | Buy |
|
|||||
|
2020
Q4 | $9.42M | Sell |
|
|||||
|
2020
Q3 | $9.73M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.43M | Sell |
|
|||||
|
2019
Q1 | $48.7M | Buy |
|
|||||
|
2018
Q4 | $8.23M | Sell |
|
|||||
|
2018
Q3 | $53.3M | Buy |
|
|||||
|
2018
Q2 | $29.4M | Buy |
|
|||||
|
2018
Q1 | $14M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $9.23M | Sell |
|
|||||
|
2017
Q1 | $19.1M | Sell |
|
|||||
|
2016
Q4 | $27.9M | Buy |
|